Compare API3 (API3) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
API3 vs Injective — how do they compare? API3 trades at Rp3,361 (market cap Rp290,85M, Rp98,6M 24h volume), while Injective trades at Rp82,160 (market cap Rp8,16T, Rp947,87M 24h volume). The key difference: Injective is far larger — about 28055.7× API3's market cap, and API3's circulating supply is 86,4M API3 versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold API3 for 41 Days and Injective for 37 Days on average.
| API3 | INJ | |
|---|---|---|
Market Cap | Rp290,85M | Rp8,16T |
Volume (24h) | Rp98,6M | Rp947,87M |
Circulating Supply | 86,4M API3 | 100M INJ |
Typical Hold Time | 41 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
API3 is currently trading at Rp3,318 with a bearish technical outlook, showing selling pressure across moving averages while oscillators remain neutral. The token faces resistance at Rp3,448 with support at Rp3,264. With a market cap of Rp288.74 million and average hold time of 41 days, the asset demonstrates moderate holding patterns. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential rebounds from support levels, while risks involve continued selling pressure and limited fundamental catalysts. Investors should monitor for breakouts above resistance levels or significant ecosystem developments that could shift momentum.
Injective (INJ) is trading at Rp82,266 with a market cap of Rp8.23 trillion, showing a bearish technical signal driven by moving averages, while oscillators remain neutral. The asset faces resistance near Rp83,795 and finds support at Rp79,595, with on-chain data indicating an average hold time of 37 days. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.
Overall outlook is cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from support levels, but risks involve high volatility, regulatory uncertainty in crypto markets, and low trading volume depth. Investors should monitor for any ecosystem updates or shifts in market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About API3
API3 is an ERC-20 token based on the Ethereum blockchain. API3's goal is to allow decentralized versions of APIs to be built, managed, and monetized at scales. To achieve this in a fully decentralized way, the incentives of the participants are reconciled through the governance, security, and value capture utilities of the API3 token. The project has a completely open and direct governance model, where any API3 token holder can stake to obtain direct voting privileges in the API3 DAO.
Read more on API3 →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
